Report for: Multiple treatment comparisons in epilepsy monotherapy trials

Title	Multiple treatment comparisons in epilepsy monotherapy trials
Published in	Trials, November 2007
DOI	10.1186/1745-6215-8-34
Pubmed ID	17983480
Authors	Catrin Tudur Smith, Anthony G Marson, David W Chadwick, Paula R Williamson
Abstract	The choice of antiepileptic drug for an individual should be based upon the highest quality evidence regarding potential benefits and harms of the available treatments. Systematic reviews and meta-analysis of randomised controlled trials should be a major source of evidence supporting this decision making process. We summarise all available individual patient data evidence from randomised controlled trials that compared at least two out of eight antiepileptic drugs given as monotherapy.

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Ph. D. Student	8	19%
Researcher	7	16%
Student > Bachelor	5	12%
Professor > Associate Professor	5	12%
Student > Postgraduate	3	7%
Other	11	26%
Unknown	4	9%

Readers by discipline	Count	As %
Medicine and Dentistry	20	47%
Pharmacology, Toxicology and Pharmaceutical Science	4	9%
Mathematics	3	7%
Economics, Econometrics and Finance	2	5%
Neuroscience	2	5%
Other	5	12%
Unknown	7	16%

Multiple treatment comparisons in epilepsy monotherapy trials